Neogen Corp (NEOG, Financial) experienced a significant stock price surge of 5.44%. The stock is currently priced at $14.54 with a trading volume of 1.204 million shares and a turnover rate of 0.56%.
Financial reports show that Neogen Corp registered a revenue of $217 million but faced a net loss of $12.61 million, translating to an earnings per share (EPS) of -$0.06. The gross profit stood at $86.44 million, while the price-to-earnings (P/E) ratio is noted at -131.50.
Analyst ratings reveal that out of the three analysts covering the stock, 67% recommend buying, while 33% suggest holding, with no sell recommendations.
Within the life sciences sector, where Neogen operates, there was an overall increase of 0.99%. Notable gains were observed in Grail, Inc., Castle Biosciences, Inc., and Veracyte, Inc. Applied DNA Sciences, Inc., Mainz Biomed N.V., and Burning Rock Biotech also showed significant trading activity with turnover rates of 20.98%, 9.22%, and 3.92%, respectively. The stocks with the biggest price swings included Burning Rock Biotech, Mainz Biomed N.V., and Applied DNA Sciences, Inc., with fluctuations of 16.74%, 13.56%, and 11.18% respectively.
Neogen Corp, headquartered in Lansing, Michigan, specializes in developing, manufacturing, and selling food and animal safety products. The company provides diagnostics and testing for contaminants, pathogens, allergens, and drug residues in food and feed. It also offers veterinary instruments, medicines, disinfectants, and genomic services for various animals. Neogen's primary market is in the U.S., with additional operations in the UK and other countries.
